Adagene Inc (ADAG)
2.32
-0.09
(-3.73%)
USD |
NASDAQ |
May 06, 11:46
Adagene Enterprise Value: 18.42M for May 3, 2024
Enterprise Value Chart
Historical Enterprise Value Data
Date | Value |
---|---|
May 03, 2024 | 18.42M |
May 02, 2024 | 18.42M |
May 01, 2024 | 14.89M |
April 30, 2024 | 11.80M |
April 29, 2024 | 11.36M |
April 26, 2024 | 17.54M |
April 25, 2024 | 15.77M |
April 24, 2024 | 33.43M |
April 23, 2024 | 29.02M |
April 22, 2024 | 32.55M |
April 19, 2024 | 28.58M |
April 18, 2024 | 28.58M |
April 17, 2024 | 23.72M |
April 16, 2024 | 31.23M |
April 15, 2024 | 26.81M |
April 12, 2024 | 28.75M |
April 11, 2024 | 36.53M |
April 10, 2024 | 44.03M |
April 09, 2024 | 44.03M |
April 08, 2024 | 36.97M |
April 05, 2024 | 37.85M |
April 04, 2024 | 46.68M |
April 03, 2024 | 40.06M |
April 02, 2024 | 44.47M |
April 01, 2024 | 55.07M |
Date | Value |
---|---|
March 28, 2024 | 35.64M |
March 27, 2024 | 24.60M |
March 26, 2024 | 22.84M |
March 25, 2024 | 25.04M |
March 22, 2024 | 23.28M |
March 21, 2024 | 27.25M |
March 20, 2024 | 37.85M |
March 19, 2024 | 36.08M |
March 18, 2024 | 40.06M |
March 15, 2024 | 37.63M |
March 14, 2024 | 38.29M |
March 13, 2024 | 36.97M |
March 12, 2024 | 43.15M |
March 11, 2024 | 40.28M |
March 08, 2024 | 36.53M |
March 07, 2024 | 37.85M |
March 06, 2024 | 38.73M |
March 05, 2024 | 51.10M |
March 04, 2024 | 48.89M |
March 01, 2024 | 56.84M |
February 29, 2024 | 53.31M |
February 28, 2024 | 54.50M |
February 27, 2024 | 56.71M |
February 26, 2024 | 61.12M |
February 23, 2024 | 56.26M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-112.38M
Minimum
Oct 31 2022
1.198B
Maximum
Feb 09 2021
123.09M
Average
-25.18M
Median
Enterprise Value Benchmarks
Sinovac Biotech Ltd | -7.011B |
CASI Pharmaceuticals Inc | 25.58M |
Zai Lab Ltd | 805.69M |
I-MAB | -167.41M |
Gracell Biotechnologies Inc (DELISTED) | -- |
Enterprise Value Related Metrics
Earnings Yield | -18.86% |
Normalized Earnings Yield | -19.89 |